Explore All Access
Check if your research matches the topics covered in Current Drug Safety?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Drug Safety : Impact Factor & More
eISSN: 2212-3911pISSN: 1574-8863
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Current Drug Safety Key Metrics
CiteScore 
2.9
SJR
Q4Toxicology
SNIP
0.68
Topics Covered on Current Drug Safety
Psoriasis
Antimicrobial
Rash
Xylometazoline
Minocycline
Ethambutol
Cardiovascular safety
Antidiabetic agents
Bisoprolol
Delirium
Metformin
Type 2 Diabetes Mellitus
Sulfonylurea
Alpha-glucosidase inhibitor
Lichenoid drug eruption
Heart failure
Levofloxacin
Semaglutide
Potentially Inappropriate Medications
Safety profile
Current Drug Safety Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL |
| Language | English |
| Frequency | Tri-annual |
| General Details | |
| Language | English |
| Frequency | Tri-annual |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Drug Safety
SGLT-2 Inhibitors as an Effective Treatment for Type 2 Diabetes Mellitus, Hypertension, and Hyperuricemia - A Mechanistic Perspective.
- 22 Nov 2024
- Current drug safety
Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the Literature.
- 5 Nov 2024
- Current drug safety
Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review.
- 1 Nov 2024
- Current drug safety
Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures.
- 1 Nov 2024
- Current drug safety
A Review of Drug Abuse, Misuse, and Related Laboratory Challenges.
- 1 Nov 2024
- Current drug safety
Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran) Vaccination: Two Case-Reports with Positive Rechallenge and Review of the Literature.
- 1 Nov 2024
- Current drug safety
SGLT-2 Inhibitors as an Effective Treatment for Type 2 Diabetes Mellitus, Hypertension, and Hyperuricemia - A Mechanistic Perspective.
- 22 Nov 2024
- Current drug safety
Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the Literature.
- 5 Nov 2024
- Current drug safety
Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review.
- 1 Nov 2024
- Current drug safety
Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures.
- 1 Nov 2024
- Current drug safety
A Review of Drug Abuse, Misuse, and Related Laboratory Challenges.
- 1 Nov 2024
- Current drug safety
Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran) Vaccination: Two Case-Reports with Positive Rechallenge and Review of the Literature.
- 1 Nov 2024
- Current drug safety
Compare Similar Journals with Current Drug Safety
Select Journals to Compare with Current Drug Safety
Total journals - 8
You can select up to 3 Journals at a time
Medicine
Publisher: Elsevier
Diabetes, Obesity and Metabolism
Publisher: WILEY
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Journal of the Endocrine Society
Publisher: Endocrine Society
Diabetes Therapy
Publisher: SPRINGER HEIDELBERG
International Journal of Environmental Research and Public Health
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
0 Journals Selected to compare with
Current Drug Safety
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Current Drug Safety
How long has Current Drug Safety been actively publishing? 
Current Drug Safety has been in operation since 2006 till date.
What is the publishing frequency of Current Drug Safety?
Current Drug Safety published with a Tri-annual frequency.
How many articles did Current Drug Safety publish last year?
In 2023, Current Drug Safety publsihed 85 articles.
What is the eISSN & pISSN for Current Drug Safety?
For Current Drug Safety, eISSN is 2212-3911 and pISSN is 1574-8863.
What is Citescore for Current Drug Safety?
Citescore for Current Drug Safety is 2.9.
What is SNIP score for Current Drug Safety?
SNIP score for Current Drug Safety is 0.68.
What is the SJR for Current Drug Safety?
SJR for Current Drug Safety is Q4.
Who is the publisher of Current Drug Safety?
BENTHAM SCIENCE PUBL is the publisher of Current Drug Safety.
Your document is 100% secure & confidential 
